Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Rentokil RTO Stock Is It Trading at Premium Rentokil posts 173 EPS miss vs street estimates NGG National delivers 57 Q1 2026 EPS upside shares dip 023 on lukewarm investor reaction Is Amplify AMPY stock maintaining its trend Q4 2025 EPS Beats Forecasts Betterware BWMX Complete Analysis Q4 2025 Earnings Underperform NEN New posts 108 percent year over year Q4 2024 revenue growth shares rise 172 percent today What failed trades Xilio Therapeutics XLO Slight Gain 20260427 How Vaxcyte PCVX management quality drives results Avalanches 20260508 KraneShares CSI China Internet UCITS ETF KWEB Expands European Distribution with EUR GBP Hedged LSE Listings CALX Calix Q1 revenue surges 203 YoY but shares retreat 185 despite meeting estimates Crit Metals CRMLW Slips 344 Testing 427 Support 20260518 Anthropic Hires OpenAI CoFounder Andrej Karpathy Former Tesla AI Leader Presurance PRHIZ Flat at 1758 Consolidation Continues 20260514 Latham Group SWIM Stock Down 124 Support Test at 454 20260519 Praxis PRAX Q1 2026 Crushes Forecasts EPS 320 vs 362 Wen WENN Stalls at 1026 Breakout or Breakdown 20260520 TrumpBacked Investment Fuels Kura Sushis US Expansion Ambitions Kawasaki Heavy Partners with Nvidia to Advance Physical AI Plans US Robotics Center Silver Prices Decline on Wednesday May 27 2026 SpaceX Successfully Launches Starship on Second Attempt Advancing DeepSpace Ambitions ixigo Partners with Uber and redBus to Integrate Cab and Bus Booking within Trains App Federal vs Private Student Loans Key Differences and Expert Recommendations UKGulf Trade Deal Hailed as Monumental Achievement by Bahrain Minister Disneys Star Wars The Mandalorian and Grogu Opens with FranchiseLow Thursday Previews of 12 Million GWH Q1 2026 Earnings EPS Misses Estimates Amid PreRevenue Stage GLIBA Q1 2026 Earnings Significant Earnings Miss as EPS Falls Well Below Estimates IDR Q1 2026 Earnings EPS Misses Estimates as Stock Slips 29 DAWN Q4 2025 Earnings Miss on EPS as PreRevenue Biotech Invests in Pipeline Fortis Inc FTS Q1 2026 Earnings Modest EPS Miss Amid Steady Utility Performance Ionis Pharmaceuticals IONS Edges Higher as Biotech Sector Holds Steady Jupiter Neurosciences JUNS Slips 328 as Shares Test Critical Support at 022 Global Industrial Company GIC Edges Higher Amid Steady Trading TransMedics Group TMDX Moves Higher Key Support and Resistance Levels in Focus